SK282947B6 - Použitie interleukínu-10 alebo jeho analógu, agonistu alebo antagonistu na výrobu farmaceutického prostriedku - Google Patents
Použitie interleukínu-10 alebo jeho analógu, agonistu alebo antagonistu na výrobu farmaceutického prostriedku Download PDFInfo
- Publication number
- SK282947B6 SK282947B6 SK129-94A SK12994A SK282947B6 SK 282947 B6 SK282947 B6 SK 282947B6 SK 12994 A SK12994 A SK 12994A SK 282947 B6 SK282947 B6 SK 282947B6
- Authority
- SK
- Slovakia
- Prior art keywords
- cells
- mice
- lps
- tnfα
- ifnγ
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5428—IL-10
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
- C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Neurosurgery (AREA)
- Zoology (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Transplantation (AREA)
- Virology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74212991A | 1991-08-06 | 1991-08-06 | |
PCT/US1992/006378 WO1993002693A2 (en) | 1991-08-06 | 1992-08-06 | Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
Publications (2)
Publication Number | Publication Date |
---|---|
SK12994A3 SK12994A3 (en) | 1994-12-07 |
SK282947B6 true SK282947B6 (sk) | 2003-01-09 |
Family
ID=24983602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK129-94A SK282947B6 (sk) | 1991-08-06 | 1992-08-06 | Použitie interleukínu-10 alebo jeho analógu, agonistu alebo antagonistu na výrobu farmaceutického prostriedku |
Country Status (17)
Country | Link |
---|---|
EP (2) | EP0600970B1 (cs) |
JP (3) | JPH07502019A (cs) |
KR (1) | KR100271197B1 (cs) |
AT (1) | ATE187336T1 (cs) |
AU (1) | AU678137B2 (cs) |
CA (1) | CA2115060C (cs) |
CZ (1) | CZ281796B6 (cs) |
DE (1) | DE69230403T2 (cs) |
DK (1) | DK0600970T3 (cs) |
ES (1) | ES2138976T3 (cs) |
FI (1) | FI940519A0 (cs) |
GR (1) | GR3032167T3 (cs) |
HU (1) | HU224437B1 (cs) |
NO (1) | NO315409B1 (cs) |
PT (1) | PT600970E (cs) |
SK (1) | SK282947B6 (cs) |
WO (1) | WO1993002693A2 (cs) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993018783A1 (en) * | 1992-03-20 | 1993-09-30 | Schering Corporation | Use of interleukin-10 to induce the production of interleukin-1 receptor antagonist |
CA2144648A1 (en) * | 1992-09-18 | 1994-03-31 | Mario Clerici | Restoration of immunocompetency to t helper cells in hiv infected patients |
AU6000894A (en) * | 1993-02-01 | 1994-08-29 | Michel Goldman | Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10 |
IL110413A0 (en) * | 1993-07-26 | 1994-10-21 | Schering Corp | Agonists and antagonists of human interleukin-10 |
AP690A (en) * | 1994-07-05 | 1998-10-16 | Steeno Res Group A/S | Immunomodulators based on a polypeptide other than human interleukin 10. |
US5753218A (en) * | 1996-05-03 | 1998-05-19 | Schering Corporation | Method for treating inflammation |
WO2002066069A1 (fr) * | 2001-02-20 | 2002-08-29 | Kansai Technology Licensing Organization Co., Ltd. | Remedes contre l'inflammation/les maladies tumorales |
PE20090046A1 (es) | 2003-11-10 | 2009-01-26 | Schering Corp | Anticuerpo recombinante humanizado anti-interleuquina 10 |
WO2011064398A1 (en) | 2009-11-30 | 2011-06-03 | Biotest Ag | Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle) |
BR112015018834A2 (pt) | 2013-03-20 | 2017-07-18 | Hoffmann La Roche | método para a detecção de um anticorpo do rato, utilização de uma mistura de anticorpos monoclonais e utilização de um anticorpo |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL94878A (en) * | 1989-06-28 | 2003-01-12 | Schering Corp | Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same |
CZ283049B6 (cs) * | 1989-12-20 | 1997-12-17 | Schering Corporation | Protein BCRF1 viru Epstein-Barr schopný inhibovat syntézu gama-interferonu, expresní vekter pro jeho syntézu a farmaceutický přípravek jej obsahující |
-
1992
- 1992-08-06 CA CA002115060A patent/CA2115060C/en not_active Expired - Fee Related
- 1992-08-06 PT PT92917650T patent/PT600970E/pt unknown
- 1992-08-06 WO PCT/US1992/006378 patent/WO1993002693A2/en active IP Right Grant
- 1992-08-06 AT AT92917650T patent/ATE187336T1/de not_active IP Right Cessation
- 1992-08-06 AU AU24411/92A patent/AU678137B2/en not_active Ceased
- 1992-08-06 KR KR1019940700386A patent/KR100271197B1/ko not_active IP Right Cessation
- 1992-08-06 CZ CS94243A patent/CZ281796B6/cs not_active IP Right Cessation
- 1992-08-06 SK SK129-94A patent/SK282947B6/sk not_active IP Right Cessation
- 1992-08-06 EP EP92917650A patent/EP0600970B1/en not_active Expired - Lifetime
- 1992-08-06 JP JP5503756A patent/JPH07502019A/ja not_active Withdrawn
- 1992-08-06 DE DE69230403T patent/DE69230403T2/de not_active Expired - Fee Related
- 1992-08-06 HU HU9400314A patent/HU224437B1/hu not_active IP Right Cessation
- 1992-08-06 ES ES92917650T patent/ES2138976T3/es not_active Expired - Lifetime
- 1992-08-06 EP EP19920307212 patent/EP0541214A3/en active Pending
- 1992-08-06 DK DK92917650T patent/DK0600970T3/da active
-
1994
- 1994-02-04 FI FI940519A patent/FI940519A0/fi unknown
- 1994-02-04 NO NO19940370A patent/NO315409B1/no not_active IP Right Cessation
-
1999
- 1999-12-17 GR GR990403252T patent/GR3032167T3/el unknown
-
2004
- 2004-03-24 JP JP2004088119A patent/JP2004250454A/ja not_active Ceased
-
2007
- 2007-08-21 JP JP2007215330A patent/JP2008013573A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2441192A (en) | 1993-03-02 |
ATE187336T1 (de) | 1999-12-15 |
CA2115060A1 (en) | 1993-02-18 |
NO940370D0 (no) | 1994-02-04 |
PT600970E (pt) | 2000-05-31 |
KR100271197B1 (ko) | 2000-11-01 |
FI940519A (fi) | 1994-02-04 |
CZ24394A3 (en) | 1995-01-18 |
FI940519A0 (fi) | 1994-02-04 |
ES2138976T3 (es) | 2000-02-01 |
CZ281796B6 (cs) | 1997-02-12 |
CA2115060C (en) | 2003-05-06 |
EP0541214A2 (en) | 1993-05-12 |
DE69230403T2 (de) | 2000-05-11 |
SK12994A3 (en) | 1994-12-07 |
WO1993002693A3 (en) | 1993-07-22 |
NO940370L (no) | 1994-02-04 |
WO1993002693A2 (en) | 1993-02-18 |
AU678137B2 (en) | 1997-05-22 |
JP2008013573A (ja) | 2008-01-24 |
EP0600970A1 (en) | 1994-06-15 |
EP0541214A3 (en) | 1993-09-08 |
EP0600970B1 (en) | 1999-12-08 |
HUT66865A (en) | 1995-01-30 |
DK0600970T3 (da) | 2000-05-29 |
HU224437B1 (hu) | 2005-09-28 |
DE69230403D1 (de) | 2000-01-13 |
HU9400314D0 (en) | 1994-05-30 |
JPH07502019A (ja) | 1995-03-02 |
GR3032167T3 (en) | 2000-04-27 |
JP2004250454A (ja) | 2004-09-09 |
NO315409B1 (no) | 2003-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5837232A (en) | Use of an interleukin-10 antagonist to treat a B cell mediated autoimmune disorder | |
Kishimoto | B-cell stimulatory factors (BSFs): molecular structure, biological function, and regulation of expression | |
US5776451A (en) | Use of interleukin-10 in adoptive immunotherapy of cancer | |
KR0183035B1 (ko) | 사람 사이토킨 합성 억제 인자 및 이의 길항제 | |
JP2008013573A (ja) | 内毒素または超抗原に誘導された毒性を治療するインターロイキン−10類似体またはアンタゴニストの使用 | |
EP0801951A2 (en) | Novel uses of Il-4 and/or Il-10, and antibodies against the same | |
CZ282523B6 (cs) | Iterleukin - 10 pro léčení nádorů, farmaceutický prostředek jej obsahující, jeho použití a způsob výroby | |
EP0629130A1 (en) | Use of interleukin-10 to suppress graft-vs.-host disease | |
US6207154B1 (en) | Methods of treatment using antagonists of cytokine synthesis inhibitory factor | |
US6319493B1 (en) | Treatment of neoplastic disease with interleukin-10 | |
CA2079230C (en) | Bcrf1 antagonists for treating epstein-barr virus infections | |
Shurin et al. | Interleukin-15 and 21 | |
IE902346L (en) | Cytokine synthesis inhibitory factor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20090806 |